Tema Oncology ETF
CANC
15 hedge funds and large institutions have $20.8M invested in Tema Oncology ETF in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
25% more funds holding
Funds holding: 12 → 15 (+3)
3.53% less ownership
Funds ownership: 13.99% → 10.46% (-3.5%)
11% less capital invested
Capital invested by funds: $23.5M → $20.8M (-$2.63M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$1.52M |
| 2 |
LPL Financial
San Diego,
California
|
+$1.38M |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$1.1M |
| 4 |
OIM
Oder Investment Management
Woodland Hills,
California
|
+$470K |
| 5 |
PIA
Perennial Investment Advisors
Los Angeles,
California
|
+$447K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.54M |
| 2 |
Jane Street
New York
|
-$2.31M |
| 3 |
FTUS
Flow Traders U.S.
New York
|
-$785K |
CANC Hedge Fund Activity: Q2 2026 in Review
15 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q2 2026, worth a combined $20.8M — down 11% from $23.5M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CANC positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $1.52M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.54M sold.
- 15 institutional investors held Tema Oncology ETF (CANC) as of Q2 2026, up from 12 in Q1 2026.
- Funds reported $20.8M of Tema Oncology ETF stock for Q2 2026, down 11% quarter-over-quarter.
- 6 funds opened new Tema Oncology ETF positions in Q2 2026 and 2 closed out, a net change of +4 holders.
- The largest Tema Oncology ETF buyer in Q2 2026 was Thrivent Financial for Lutherans, an estimated $1.52M added.
- The largest Tema Oncology ETF seller in Q2 2026 was Citadel Advisors, an estimated $2.54M sold.
Based on aggregated 13F filings for Q2 2026.